Related Experiment Video
Updated: Jun 24, 2026
19:05
Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay
Published on: October 30, 2015
12.3K
CD95/Fas stoichiometry in future precision medicine
Mauricio Sica1, Murielle Roussel2,3, Patrick Legembre4
1CONICET, Instituto Balseiro (UNCuyo), Departamento de Física Médica (GAANS-CNEA), Bariloche Atomic Center, Av. Bustillo 9500, Bariloche, Río Negro, Argentina. mp.sica@gmail.com.
Cell Death and Differentiation
|April 15, 2025
Summary
CD95 (Fas) receptor pre-associates on the cell membrane. Understanding its structure is key to developing drugs for immune disorders, as mutations cause autoimmunity and inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Structural Biology
Background:
- CD95 (Fas) is a TNF receptor superfamily member crucial for immune response regulation.
- Dysregulation of CD95 signaling is linked to autoimmune diseases and inflammation.
- CD95 undergoes ligand-independent pre-association via its pre-ligand assembly domain (PLAD).
Purpose of the Study:
- To explore the predicted conformation of CD95 at the plasma membrane.
- To understand how CD95's structure relates to cell signaling induction.
- To identify potential drug targets within the CD95 PLAD.
Main Methods:
- Comparative analysis of known TNF receptor structures.
- In silico modeling of CD95 conformation.
- Discussion of potential signaling mechanisms based on predicted structures.
Main Results:
- CD95 exhibits ligand-independent pre-association through its PLAD.
- The precise stoichiometry and conformation of CD95 remain undetermined.
- Predicted structures offer insights into CD95 signaling pathways.
Conclusions:
- Understanding CD95 conformation is critical for therapeutic development.
- Targeting the PLAD could offer novel strategies for treating immune-related disorders.
- Further structural studies are needed to elucidate CD95 function.
